Abstract
Background Motivated by the findings that exposure to daily outdoor PM2.5 (P) may increase the risk of influenza infection, our study examines if immediate exposure to outdoor P will modify the rate of change in the daily number of COVID-19 infections (R), for (1) 31 Chinese provincial capital cities and (2) Wuhan, China, using regression modelling. Effective public health measures for reducing R are recommended.
Method A multiple linear regression model was constructed to model the statistical relationship between P and R in China and in Wuhan, from 1 January to 20 March 2020. We carefully accounted for potential key confounders and addressed collinearity. The causal relationship between P and R, and the interaction effect between key variables were investigated.
Finding A causal relationship between P and R across 31 provincial capital cities in China was established via matching. A higher P resulted in a higher R in China. A 10 µg/m3 increase in P gave a 0.9% increase in R (p < 0.05). An interaction analysis between P and absolute humidity (AH) showed a statistically significant positive relationship between P × AH and R (p < 0.01). When AH was ≤ 8.6 g/m3, higher P and AH gave a higher R (p < 0.01).
Interpretation Given that P can exacerbate R, we recommend the installation of air purifiers and improving air ventilation to reduce the effect of P on R. Given that an increasing AH that falls below 8.6 g/m3 exacerbated R, dehumidifiers can be used to reduce AH and R. Further, given the increasing discussions/observations that COVID-19 can be airborne, surgical masks should be used to protect one from contracting the virus via the viral-particulate transmission pathway.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is supported in part by the Theme-based Research Scheme of the Research Grants Council of Hong Kong, under Grant No. T41-709/17-N.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee approval was not required because this study used only secondary aggregated health data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated analysis for (1) 31 provincial capital cities in China and (2) Wuhan only.
Data Availability
The datasets are available from the corresponding authors on reasonable request.
